MABLIN POWDER 1％ (マブリン散1％)

País: Japón

Idioma: inglés

Fuente: すりの適正使用協議会 RAD-AR Council, Japan

Ingredientes activos:

Busulfan

Disponible desde:

OHARA Pharmaceutical Co.,Ltd.

Designación común internacional (DCI):

Busulfan

formulario farmacéutico:

white to yellowish white powder

Información para el usuario

Drug Information Sheet("Kusuri-no-Shiori")
Internal
Published: 09/2009
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
MABLIN POWDER 1％
ACTIVE INGREDIENT:
Busulfan
DOSAGE FORM:
white to yellowish white powder
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine inhibits DNA synthesis which is essential for
multiplication of cells and
consequently suppresses overgrowth of abnormal cells.
It is usually used to improve subjective/objective symptoms of chronic
myelogenous leukemia
or polycythemia vera.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you ever experienced any allergic reaction (itch, rash etc.) to
any medicines or foods.
If you are a patient with hepatic/renal disorder, myelosuppression,
coexisting infection, lung
disorder or chicken pox.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・General dosage regimen:
For treatment of chronic myelogenous leukemia, (method 1) for adults,
take 0.4-0.6 g (4-6
mg of the active ingredient) a day. After monitoring your level of
white blood cells decreases
to near the baseline (15,000/mm
3
) the dose is decreased to 0.2 g (2 mg) or less a day.
(method 2) For adults, take 0.2 g (2 mg of the active ingredient) or
less a da